{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:14:28Z","timestamp":1684469668283},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/ncpcardio0612","type":"journal-article","created":{"date-parts":[[2006,7,28]],"date-time":"2006-07-28T06:53:20Z","timestamp":1154069600000},"page":"412-413","source":"Crossref","is-referenced-by-count":0,"title":["Should patients with mitral stenosis and atrial fibrillation receive combined antithrombotic therapy?"],"prefix":"10.1038","volume":"3","author":[{"given":"Vittorio","family":"Pengo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpcardio0612_CR1","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1055\/s-0037-1613584","volume":"89","author":"V Pengo","year":"2003","unstructured":"Pengo V  et al. (2003) Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment. Thromb Haemost 89: 760\u2013764","journal-title":"Thromb Haemost"},{"key":"BFncpcardio0612_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AG Turpie","year":"1993","unstructured":"Turpie AG  et al. (1993) A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 329: 524\u2013529","journal-title":"N Engl J Med"},{"key":"BFncpcardio0612_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","volume":"360","author":"RF van Es","year":"2002","unstructured":"van Es RF  et al. (2002) Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2study): a randomised controlled trial. Lancet 360: 109\u2013113","journal-title":"Lancet"},{"key":"BFncpcardio0612_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa020496","volume":"347","author":"M Hurlen","year":"2002","unstructured":"Hurlen M  et al. (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347: 969\u2013974","journal-title":"N Engl J Med"}],"container-title":["Nature Clinical Practice Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0612","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpcardio0612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:38:54Z","timestamp":1684438734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpcardio0612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["BFncpcardio0612"],"URL":"https:\/\/doi.org\/10.1038\/ncpcardio0612","relation":{},"ISSN":["1743-4297","1743-4300"],"issn-type":[{"value":"1743-4297","type":"print"},{"value":"1743-4300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}